Senators Baldwin and Markey Lead Group of Senators to Combat Prescription Drug Abuse Crisis
“It is critical that we make a strong commitment to strengthen our nation’s efforts to combat this epidemic.”
WASHINGTON, D.C. – U.S. Senators Tammy Baldwin (D-WI) and Edward Markey (D-MA) led a group of 16 Senators in a letter urging for increased funding for critical prescription drug abuse prevention, treatment and research programs at the Department of Health and Human Services. In the letter to U.S. Senate appropriators, the senators request the nation’s response to the prescription opioid and heroin-related abuse and overdose epidemic to be strengthened through additional funding in fiscal year (FY) 2016.
“Prescription and illicit drug abuse is an epidemic in the United States that continues to grow at an alarming rate. Drug overdose deaths have skyrocketed in the past decade, largely because of prescription opioids, and they have become the leading cause of injury death in the U.S.,” the senators wrote. “It is critical that we make a strong commitment to strengthen our nation’s efforts to combat this epidemic.”
In 2012, drug overdoses caused more deaths than motor vehicle accidents among Americans aged 25 to 64. For each death involving prescription opioids, hundreds of people abuse or misuse these drugs, leading to a staggering increase in hospital visits in the last few years. Addiction to prescription drugs often leads to the use of illicit drugs such as heroin, and as the abuse of prescription drugs has increased, so too has the abuse of heroin.
In the letter to U.S. Senate Appropriations Subcommittee on Labor, Health and Human Services, Education and Related Agencies Chairman Roy Blunt (R-MO) and Ranking Member Patty Murray (D-WA), the senators called for increased funding for domestic prescription drug abuse prevention, treatment, and research through the Centers for Disease Control and Prevention (CDC), Substance Abuse and Mental Health Services Administration (SAMHSA) and the National Institutes of Health (NIH). Increased funding in FY 2016 for critical initiatives at the CDC, SAMHSA and NIH is supported by the President’s FY 2016 budget, and will help reduce deaths and improve the nation’s health and safety.
Joining Senators Baldwin and Markey in signing the letter were Senators Joe Manchin (D-WV), Chuck Schumer (D-NY), Bernard Sanders (I-VT), Al Franken (D-MN), Tim Kaine (D-VA), Dianne Feinstein (D-CA), Dick Durbin (D-IL), Jeanne Shaheen (D-NH), Ron Wyden (D-OR), Sherrod Brown (D-OH), Angus King (I-ME), Elizabeth Warren (D-MA), Mazie K. Hirono (D-HI) and Richard Blumenthal (D-CT).
An online version of the letter can be found here.
Press Releases by Tammy Baldwin
U.S. Senator Tammy Baldwin Releases Statement on Nomination of Wealthy Insider with Deep Roots on Wall Street for Treasury SecretaryNov 30th, 2016 by Tammy Baldwin
“Wisconsin families struggling to get ahead do not want foxes guarding the hen house.”
Legislation aids Great Lakes communities by delivering next generation coastal data
U.S. Senator Tammy Baldwin Votes for Bipartisan Reform to Increase Access to High Quality Health Care in Rural WisconsinNov 29th, 2016 by Tammy Baldwin
Rural communities in Wisconsin and across the country face many challenges in accessing high-quality health care.
U.S. Senators Tammy Baldwin, Jeanne Shaheen, Ed Markey, and Joe Donnelly Call for Investments to Fight Opioid Epidemic in 21st Century Cures ActNov 23rd, 2016 by Tammy Baldwin
In the letter to Majority Leader McConnell and Minority Leader Reid, the Senators stressed the need to provide immediate funding to address the opioid epidemic.
U.S. Senator Tammy Baldwin and Mayor Tom Barrett Announces $6 Million for Workforce Development to Employ MilwaukeeNov 17th, 2016 by Tammy Baldwin
The funds will be used to train 1,430 individuals, and coordinate regional planning to attract and retain businesses.
U.S. Senator Tammy Baldwin Calls on President-Elect Trump to Keep His Promise to Make Washington Work for Wisconsin, Not Wall StreetNov 17th, 2016 by Tammy Baldwin
Close the revolving door between Wall Street and Washington